17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

Joanna M. Day; Paul A. Foster; Helena J. Tutill; Michael F. C. Parsons; Simon P. Newman; Surinder K. Chander; Gillian M. Allan; Harshani R. Lawrence; Nigel Vicker; Barry V. L. Potter; Michael J. Reed; Atul Purohit

doi:10.1002/ijc.23350

17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

Joanna M. Day, Paul A. Foster, Helena J. Tutill, Michael F. C. Parsons, Simon P. Newman, Surinder K. Chander, Gillian M. Allan, Harshani R. Lawrence, Nigel Vicker, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Department of Life Sciences

Research output: Contribution to journal › Article › peer-review

103 Citations (SciVal)

Original language	English
Pages (from-to)	1931-1940
Journal	International Journal of Cancer
Volume	122
Issue number	9
DOIs	https://doi.org/10.1002/ijc.23350
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.23350

Cite this

Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., Reed, M. J., & Purohit, A. (2008). 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. International Journal of Cancer, 122(9), 1931-1940. https://doi.org/10.1002/ijc.23350

Day, JM, Foster, PA, Tutill, HJ, Parsons, MFC, Newman, SP, Chander, SK, Allan, GM, Lawrence, HR, Vicker, N, Potter, BVL, Reed, MJ & Purohit, A 2008, '17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer', International Journal of Cancer, vol. 122, no. 9, pp. 1931-1940. https://doi.org/10.1002/ijc.23350

@article{19609045b0344b0185dcf16859524761,

title = "17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer",

author = "Day, {Joanna M.} and Foster, {Paul A.} and Tutill, {Helena J.} and Parsons, {Michael F. C.} and Newman, {Simon P.} and Chander, {Surinder K.} and Allan, {Gillian M.} and Lawrence, {Harshani R.} and Nigel Vicker and Potter, {Barry V. L.} and Reed, {Michael J.} and Atul Purohit",

year = "2008",

doi = "10.1002/ijc.23350",

language = "English",

volume = "122",

pages = "1931--1940",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

AU - Day, Joanna M.

AU - Foster, Paul A.

AU - Tutill, Helena J.

AU - Parsons, Michael F. C.

AU - Newman, Simon P.

AU - Chander, Surinder K.

AU - Allan, Gillian M.

AU - Lawrence, Harshani R.

AU - Vicker, Nigel

AU - Potter, Barry V. L.

AU - Reed, Michael J.

AU - Purohit, Atul

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=40749094550&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1002/ijc.23350

U2 - 10.1002/ijc.23350

DO - 10.1002/ijc.23350

M3 - Article

SN - 0020-7136

VL - 122

SP - 1931

EP - 1940

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 9

ER -

17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

UN SDGs

Access to Document

Other files and links

Cite this